JDD Special Focus

Acne Supplements

Stay up-to-date on new clinical findings on Acne. View the latest articles, case reports, editorial features, supplements, Podcast episodes and more!

 

Supplements

Androgens, Androgen Receptors, and the Skin

Kircik, L.H. et al.

Of the four primary pathogenic factors that drive acne vulgaris—androgen excess, increased sebum production, faulty keratinization, and overgrowth of C. acnes—androgen excess has been the most elusive therapeutic target. Oral contraceptive pills (OCPs) have direct effect on circulating hormones, but their potential use is limited to a subset of women. As such, a sizable portion of the population affected by acne vulgaris cannot even consider treatment with OCPs. While these systemic agents are generally associated with a low risk profile and have a history of safe and effective use, they are not entirely risk-free. Indirect androgen modulation has become increasingly popular. Again, while generally safe and effective, this systemic treatment is not without risks and contraindications and it is also limited to a subset of female patients.

 

Topical Vehicle Formulations in the Treatment of Acne

Kircik, L.H. et al.

Acne vulgaris (AV) is one of the most common diseases that we encounter in our clinics every day. Yet, despite the dermatology community’s perceived familiarity with acne vulgaris, it is worthwhile to note that we continue to learn more and more about the epidemiology and the pathogenesis of AV as well as novel therapeutic options. Patients with acne desire clearance. Dermatology providers today have more options than ever to tailor treatment to each patient’s needs, in light of current best evidence regarding the pathogenesis and treatment of the disease. While no new chemical entities for topical delivery have revolutionized our approach to acne management, ongoing evolution in topical vehicle formulation is optimizing therapeutic benefit and the patient experience, leading to better clinical outcomes.

 

Matrix Revisited: Innovative Approach for Specific Retinoid

Kircik, L.H. et al.

The history of a specific retinoid and the use in dermatology is a testament both to the drug’s well-established efficacy and its potential to cause skin irritation. Over more than four decades, the drug that launched the retinoid class into the market has been used in the topical management of acne, either alone or in combination. In fact, current consensus acne treatment guidelines rely heavily on retinoids, as they address several aspects of acne pathogenesis— they are comedolytic, resolve the precursor microcomedone, and are anti-inflammatory— without posing any risk for antibiotic resistance.1

Sponsored

Podcast Episodes

Ask the Investigator: Acne, OCPs, and a Side Order of Practical Pearls for the Adolescent Patient

JDD Podcast host Dr. Adam Friedman gets first-hand insight from internationally acclaimed pediatric dermatologist Dr. Lawrence Eichenfield on his recent study entitled “Hormonal Contraceptives and Acne: A Retrospective Analysis of 2147 Patients” published in the June 2016 edition of the Journal of Drugs of Dermatology. Want a refresher on the use of OCPs in Acne?

Interested in learning how to initiate a patient based survey study? Just curious how a leader in the field gets an uninterested adolescent to be compliant and engaged in his/her acne care? These are just a few of the practical pearls provided.

Listen Now

Sponsored

Featured Case Report

Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study

There is a need for new oral antibiotics for acne with improved safety profiles and targeted antibacterial spectra. Sarecycline is a novel, tetracycline-class antibiotic specifically designed for acne, offering a narrow spectrum of activity compared with currently available tetracyclines, including less activity against enteric Gram-negative bacteria. This phase 2 study evaluated the efficacy and safety of three doses of sarecycline for moderate to severe facial acne vulgaris.

 

Read Now

Featured Editorial

Virtual Exams No Substitute for In-Person Care of Acne and Rosacea

Some dermatologists may be surprised to hear that the concept of teledermatology originated 25 years ago, and has slowly increased in usage, primarily for the purpose of providing care to those in underserved areas.1 The challenges created by the COVID19 pandemic has rapidly accelerated both interest and usage of telemedicine by dermatologists, with the American Academy of Dermatology and other dedicated groups responding quickly to provide guidance on how to integrate teledermatology into real-world dermatology practice effectively, and hopefully with avoidance of technical, medicolegal, and financial pitfalls.2
Read Now

Dermatology News

JDD HighlightsJDD WebinarsThe Latest
October 29, 2024

Caring for Sexual and Gender Diverse Patients in Dermatology – Supported by La Roche-Posay

The goals of this webinar include defining basic terminology and concepts related to sex, gender, and sexual orientation; reviewing demographic characteristics and health policy considerations relevant to the care of…
JDD HighlightsJDD WebinarsThe Latest
October 25, 2024

New Innovations with SkinCeuticals HA Intensifier Multi-Glycan

Active ingredients play a critical role in the efficacy and safety of cosmeceuticals. Join Dr. DiAnne Davis, as she shares information on a new cosmeceutical formulation. This presentation will include…
Atopic DermatitisJDD HighlightsRosaceaSkin Barrier FunctionThe LatestVideo Pearls
October 24, 2024

Efficacy and Tolerance of a Polymeric Surfactant Technology-Based Cleanser for Clinically Diagnosed Sensitive Skin

Cleansing is a significant daily hygiene step used by many to fight against infections and keep the skin healthy. However, cleansing also presents new challenges in the face of skin…
Atopic DermatitisDermatology RoundupJDD HighlightsJDD in the MediaThe Latest
October 17, 2024

Dermatology Roundup: Semaglutide for HS, Acne Laser Receives FDA Clearance

By Allison Sit Semaglutide – a glucagon-like peptide (GLP)-1RA – improved outcomes for obese patients with hidradenitis suppurativa (HS), according to a study presented at EADV Congress 2024. The study…